chartexchange

Prelude, Lilly Partner On Breast Cancer Combination Trial; Stock Up

RTTNews | Oct 13, 2026 8:08 AM EDT


(RTTNews) - Tuesday, Prelude Therapeutics Incorporated (PRLD) announced a clinical trial collaboration with Eli Lilly (LLY) to evaluate PRT13722 in combination with Verzenio (abemaciclib) and Inluriyo (imlunestrant) in patients with HR+/HER2- breast cancer.

Read original article